Skip to content
Disclosery

EXANE DERIVATIVES: STLA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on STLA, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 31,141 STLA shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 31,141 shares
    Change vs previous 13F -270,625 shares

    0.22% of the 13F portfolio, value $381,125.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 301,766 shares
    Change vs previous 13F -1,359,929 shares

    1.4% of the 13F portfolio, value $4,957,482.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,661,695 shares
    Change vs previous 13F +934,941 shares

    7.64% of the 13F portfolio, value $31,390,506.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 726,754 shares
    Change vs previous 13F -724,649 shares

    3.48% of the 13F portfolio, value $13,949,736.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,451,403 shares
    Change vs previous 13F +526,447 shares

    6.57% of the 13F portfolio, value $28,015,966.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 924,956 shares
    Change vs previous 13F not available

    4.93% of the 13F portfolio, value $16,355,926.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).